Jun 2026 (Q2 FY26) — Jul 28, 2026
Itron Q2 FY26 — Record Gross Margin and Strong Earnings on In-Line Revenue
Read the full callItron (ITRI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Itron earnings: last reported Tue, 28 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 563 | −7.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 13.5 | +0.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 53.3 | −22.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$82.14 −1.08% · −$0.9
Performance −37.5% 1Y
1Y: $131.33 on 17 Oct 2025 → $82.14. High $138.18 (29 Oct 2025), low $78.02 (19 May 2026).
- Previous close
- $83.04
- 52-week range
- $78.02 – $138.18
- One year
- −38.72%
Overview
- Symbol
- ITRI
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Itron earnings calls (ITRI)
Financials
What the filings say
Net profit, year on year: −22% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 615 | 613 | 607 | 607 | 582 | 572 | 587 | 563 |
| Operating profit | 74 | 63 | 76 | 76 | 82 | 79 | 68 | 76 |
| Operating margin | 12.0% | 10.2% | 12.6% | 12.6% | 14.1% | 13.8% | 11.5% | 13.5% |
| Other income | 8 | 7 | 6 | 7 | 9 | 7 | -0 | 4 |
| Interest | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Profit before tax | 82 | 70 | 82 | 83 | 91 | 86 | 67 | 80 |
| Tax rate | 4.3% | 16.1% | 20.6% | 17.6% | 27.0% | −20.1% | 20.3% | 33.3% |
| Net profit | 78 | 58 | 65 | 68 | 66 | 102 | 53 | 53 |
| EPS ($ per share) | 1.73 | — | 1.44 | 1.50 | 1.43 | — | 1.20 | 1.21 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1,334 | 1,358 | 1,389 | 1,780 | 1,788 | 1,821 | 1,690 | 1,661 |
| Reserves | -425 | -376 | -434 | -516 | -525 | -428 | -189 | 112 |
| Total liabilities | 1,875 | 1,907 | 1,767 | 1,251 | 1,187 | 1,273 | 1,996 | 1,983 |
| Fixed assets | 227 | 233 | 208 | 163 | 140 | 129 | 115 | 112 |
| Total assets | 2,609 | 2,708 | 2,607 | 2,394 | 2,378 | 2,604 | 3,408 | 3,721 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 110 | 173 | 110 | 155 | 25 | 125 | 238 | 406 |
| Cash from investing | -863 | -48 | -41 | -35 | 41 | -23 | -63 | -350 |
| Cash from financing | 396 | -98 | -12 | -153 | -19 | -4 | 580 | -97 |
| Net cash flow | -365 | 28 | 57 | -44 | 39 | 100 | 749 | -31 |
| Capital expenditure | -60 | -61 | -46 | -35 | -20 | -27 | -31 | -23 |
| Free cash flow | 50 | 112 | 63 | 120 | 5 | 98 | 208 | 383 |
Insider filings
127 filings between Nov 11, 2025 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$15.41M
82 sales by 8 insiders
17% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 43
- Award — granted as compensation
- 2
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Deitrich Thomas | — | $6.52M | Aug 24, 2026 |
| Hooper Joan S | — | $2.73M | Aug 24, 2026 |
| Marcolini John F. | — | $1.96M | Aug 24, 2026 |
| Patrick Justin K | — | $1.72M | Sep 3, 2026 |
| Reeves Donald L. III | — | $1.16M | Aug 25, 2026 |
| Ware Christopher E. | — | $659.4K | Aug 24, 2026 |
| Pulatie-Hahn Laurie Ann | — | $571.6K | Aug 24, 2026 |
| Wright David Marshall | — | $78.3K | Aug 24, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Perez Santiago Director | Award | 608 | $0 |
| Oct 1, 2026 | Lande Jerome J. Director | Award | 608 | $0 |
| Oct 1, 2026 | LEYDEN TIMOTHY M Director | Award | 243 | $0 |
| Oct 1, 2026 | Savage Sheri Director | Award | 608 | $0 |
| Oct 1, 2026 | Mirchandani Sanjay Director | Award | 608 | $0 |
| Oct 1, 2026 | Drury Scott D. Director | Award | 608 | $0 |
| Oct 1, 2026 | JAEHNERT FRANK M Director | Award | 608 | $0 |
| Sep 3, 2026 | Patrick Justin K SVP, Device Solutions | Sale 10b5-1 plan | 1,153 | $112.3K |
| Sep 3, 2026 | Patrick Justin K SVP, Device Solutions | Sale 10b5-1 plan | 581 | $56.6K |
| Sep 3, 2026 | Patrick Justin K SVP, Device Solutions | Sale 10b5-1 plan | 593 | $57.7K |
| Sep 3, 2026 | Patrick Justin K SVP, Device Solutions | Sale 10b5-1 plan | 7,883 | $767.5K |
| Aug 25, 2026 | Reeves Donald L. III SVP, Outcomes | Sale 10b5-1 plan | 283 | $28.3K |
| Aug 24, 2026 | Reeves Donald L. III SVP, Outcomes | Sale | 329 | $32.5K |
| Aug 24, 2026 | Hooper Joan S SVP & CFO | Sale | 455 | $44.9K |
| Aug 24, 2026 | Pulatie-Hahn Laurie Ann SVP, HR | Sale | 178 | $17.6K |
| Aug 24, 2026 | Marcolini John F. SVP, Networked Solutions | Sale | 331 | $32.7K |
| Aug 24, 2026 | Deitrich Thomas President & CEO | Sale | 887 | $87.6K |
| Aug 24, 2026 | Patrick Justin K SVP, Device Solutions | Sale | 222 | $21.9K |
| Aug 24, 2026 | Wright David Marshall VP, Corp. Controller & CAO | Sale | 76 | $7.5K |
| Aug 24, 2026 | Ware Christopher E. SVP, GC & Corp. Secretary | Sale | 200 | $19.8K |
| Aug 21, 2026 | Reeves Donald L. III SVP, Outcomes | Sale 10b5-1 plan | 247 | $24.4K |
| Aug 20, 2026 | Reeves Donald L. III SVP, Outcomes | Sale | 286 | $28.0K |
| Aug 20, 2026 | Ware Christopher E. SVP, GC & Corp. Secretary | Sale | 195 | $19.1K |
| Aug 20, 2026 | Pulatie-Hahn Laurie Ann SVP, HR | Sale | 187 | $18.3K |
| Aug 20, 2026 | Patrick Justin K SVP, Device Solutions | Sale | 212 | $20.7K |
| Aug 20, 2026 | Hooper Joan S SVP & CFO | Sale | 4,041 | $399.9K |
| Aug 20, 2026 | Marcolini John F. SVP, Networked Solutions | Sale | 275 | $26.9K |
| Aug 20, 2026 | Deitrich Thomas President & CEO | Sale | 783 | $76.6K |
| Aug 20, 2026 | Hooper Joan S SVP & CFO | Option exercise | 1,443 | $100.0K |
| Aug 20, 2026 | Hooper Joan S SVP & CFO | Option exercise | 4,380 | $299.8K |
| Aug 20, 2026 | Hooper Joan S SVP & CFO | Sale | 365 | $35.7K |
| Aug 20, 2026 | Wright David Marshall VP, Corp. Controller & CAO | Sale | 58 | $5.7K |
| Jul 1, 2026 | Lande Jerome J. Director | Award | 621 | $0 |
| Jul 1, 2026 | Drury Scott D. Director | Award | 621 | $0 |
| Jul 1, 2026 | Savage Sheri Director | Award | 621 | $0 |
| Jul 1, 2026 | Perez Santiago Director | Award | 621 | $0 |
| Jul 1, 2026 | Mirchandani Sanjay Director | Award | 621 | $0 |
| Jul 1, 2026 | LEYDEN TIMOTHY M Director | Award | 248 | $0 |
| Jul 1, 2026 | JAEHNERT FRANK M Director | Award | 621 | $0 |
| Jun 3, 2026 | Marcolini John F. SVP, Networked Solutions | Sale 10b5-1 plan | 11,400 | $946.1K |
| May 27, 2026 | Reeves Donald L. III SVP, Outcomes | Sale 10b5-1 plan | 293 | $24.8K |
| May 26, 2026 | Deitrich Thomas President & CEO | Sale | 862 | $72.7K |
| May 26, 2026 | Wright David Marshall VP, Corp. Controller & CAO | Sale | 74 | $6.2K |
| May 26, 2026 | Reeves Donald L. III SVP, Outcomes | Sale | 319 | $26.9K |
| May 26, 2026 | Ware Christopher E. SVP, GC & Corp. Secretary | Sale | 195 | $16.5K |
| May 26, 2026 | Marcolini John F. SVP, Networked Solutions | Sale | 322 | $27.2K |
| May 26, 2026 | Pulatie-Hahn Laurie Ann SVP, HR | Sale | 174 | $14.7K |
| May 26, 2026 | Patrick Justin K SVP, Device Solutions | Sale | 216 | $18.2K |
| May 26, 2026 | Hooper Joan S SVP & CFO | Sale | 442 | $37.3K |
| May 21, 2026 | Reeves Donald L. III SVP, Outcomes | Sale 10b5-1 plan | 255 | $20.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for ITRON, INC.
Free account. Everything above stays public.
Write why you follow ITRON, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading